metformin has been researched along with oxazoles in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Geyer, G; Sokopp, B | 1 |
| Ahn, MY; Chae, SH; Chang, TS; Han, HK; Jung, jH; Khil, LY; Kim, YC; Lee, BH; Lee, DO; Lee, YM; Moon, CK | 1 |
| Belder, R; DeFronzo, RA; Fiedorek, FT; Gross, J; Kendall, DM; Ledeine, JM; Mohideen, P; Norwood, P; O'Mahony, M; Roberts, A; Rubin, CJ; Sall, K; Sloan, G | 1 |
| Fiedorek, FT; Ledeine, JM; Rubin, CJ | 1 |
| Barreto-Torres, G; Javadov, S; Parodi-Rullán, R | 1 |
| Brito, JP; Gionfriddo, MR; Leppin, AL; Montori, VM; Morey-Vargas, OL; Murad, MH | 1 |
| Andjelkovic, M; Buse, JB; Durrwell, L; El Azzouzi, B; Henry, RR; Herz, M; Jaekel, K; Mingrino, R; Wu, H | 1 |
| Amoroso, R; Arduini, A; Cama, A; Cataldi, A; De Lellis, L; di Giacomo, V; Florio, R; Gallorini, M; Mariani-Costantini, R; Natale, A; Perconti, S; Sanna, M; Verginelli, F; Veschi, S | 1 |
| Abdulrasool, LI; Alley, SC; Dailey, B; DeChenne, S; Endres, CJ; Lee, AJ; Mayor, JG; Rustia, EL; Topletz-Erickson, AR; Walker, LN; Wise, AL | 1 |
1 review(s) available for metformin and oxazoles
| Article | Year |
|---|---|
Systematic reviews to ascertain the safety of diabetes medications.
Topics: Acidosis, Lactic; Blood Glucose; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Female; Fractures, Bone; Glycated Hemoglobin; Glycine; Humans; Hypoglycemic Agents; Male; Meta-Analysis as Topic; Metformin; Oxazoles; Pancreatic Neoplasms; Risk Assessment; Rosiglitazone; Thiazolidinediones; Urinary Bladder Neoplasms | 2014 |
4 trial(s) available for metformin and oxazoles
| Article | Year |
|---|---|
Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A
Topics: Adult; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycine; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Oxazoles; Pioglitazone; PPAR alpha; PPAR gamma; Thiazolidinediones; Triglycerides | 2006 |
Improvement of glycaemic and lipid profiles with muraglitazar plus metformin in patients with type 2 diabetes: an active-control trial with glimepiride.
Topics: Administration, Oral; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Glycine; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Lipids; Male; Metformin; Middle Aged; Oxazoles; Sulfonylurea Compounds; Time Factors; Treatment Outcome | 2008 |
Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Metformin; Middle Aged; Oxazoles; Sulfonylurea Compounds; Thiophenes | 2015 |
Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
Topics: Adolescent; Adult; Aged; Animals; Antineoplastic Agents; Biological Transport; Creatinine; Cross-Over Studies; Dogs; Female; Glomerular Filtration Rate; Healthy Volunteers; HEK293 Cells; Humans; Inhibitory Concentration 50; Madin Darby Canine Kidney Cells; Male; Metformin; Middle Aged; Organic Cation Transport Proteins; Organic Cation Transporter 2; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Young Adult | 2021 |
4 other study(ies) available for metformin and oxazoles
| Article | Year |
|---|---|
[Influence of 3,5-dimethylisoxazol short-term administration on the carbohydrate metabolism in elderly diabetics with secondary failure of sulfonylurea treatment].
Topics: Aged; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glycosuria; Humans; Hypoglycemic Agents; Injections, Intramuscular; Injections, Intravenous; Male; Metformin; Middle Aged; Oxazoles; Time Factors; Tolbutamide | 1969 |
Effects of KST48 [(2R,5SR)3-(2-chlorobenzoyl)-5-(4-chlorophenoxymethyl)-2(3,4-dichlorophenyl) oxazolidine] on glucose transport in L6 myocytes.
Topics: Antimetabolites; Cell Line; Cell Survival; Deoxyglucose; Electrophoresis, Polyacrylamide Gel; Glucose; Glucose Transporter Type 4; Hydrocarbons, Chlorinated; Hypoglycemic Agents; Immunoblotting; Insulin; Kinetics; Metformin; Monosaccharide Transport Proteins; Muscle Cells; Muscle Proteins; Myoblasts; Oxazoles; Protein Transport; Protein-Tyrosine Kinases; Subcellular Fractions | 2004 |
The role of PPARα in metformin-induced attenuation of mitochondrial dysfunction in acute cardiac ischemia/reperfusion in rats.
Topics: Animals; Electron Transport Complex I; Electron Transport Complex II; Hypoglycemic Agents; L-Lactate Dehydrogenase; Male; Metformin; Mitochondria, Heart; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxazoles; PPAR alpha; Rats; Rats, Sprague-Dawley; Tyrosine | 2012 |
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Dichloroacetic Acid; Drug Screening Assays, Antitumor; Humans; Metformin; Oxazoles; Paraganglioma; Tyrosine | 2018 |